Report cover image

Recombinant Therapeutics Antibodies and Proteins Market Size, Share, By Drug Class (Plasma Protein, Growth Factors, Fusion Protein, Monoclonal Antibodies, Hormones, Enzyme, Coagulation Factors, and Others), Host Cell Type (Mammalian Cells, Bacterial Cells

Publisher Prophecy Market Insights
Published Apr 01, 2024
Length 180 Pages
SKU # PRMI20123693

Description

Recombinant Therapeutics Antibodies and Proteins Market Size, Share, By Drug Class (Plasma Protein, Growth Factors, Fusion Protein, Monoclonal Antibodies, Hormones, Enzyme, Coagulation Factors, and Others), Host Cell Type (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others), Application (Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, and Others), End User (Biotechnology and Pharmaceutical Companies, Research Organizations and Laboratories, Diagnostic Centers, and Others), and Region - Trends, Analysis and Forecast till 2035

The Recombinant Therapeutics Antibodies and Proteins Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.

Recombinant therapeutic antibodies and proteins are genetically modified drugs that create highly specific, customized therapeutic molecules for illnesses. The recombinant therapeutics antibodies and proteins market is growing due to rising chronic disease prevalence, personalized medicine demand, biopharmaceutical research, biologics focus, and clinical trials. Improvements in genetic engineering, protein expression technologies, and new antibody technologies, such as bispecific antibodies and antibody-drug conjugates, further drive market growth.

Report Highlights:
  • Recombinant therapeutics antibodies and proteins market size is accounted at USD 227.4 Billion in 2025.
  • Target Market size is developing at a valuation of USD 960.4 Billion by 2034 and at a CAGR of 17.1%.
  • Based on drug class, the monoclonal antibodies is the drug class which is governing the recombinant therapeutics antibodies and proteins market share.
  • Dependent on host cell type, the mammalian cells is attributed to rule over the recombinant therapeutics antibodies and proteins market.
  • Based on application, the oncology segment is projected to dominate the recombinant therapeutics antibodies and proteins market.
  • On the basis of end user, the biotechnology and pharmaceutical companies is the end user which is leading the target market.
  • Under region, North America is the region which holds the superior recombinant therapeutics antibodies and proteins market share.
  • Europe is the region which is anticipated to grow with the fastest growth rate, during the forecast period, in the recombinant therapeutics antibodies and proteins market.
Key Highlights:
  • In October 2023, Proteintech, a global leader in antibodies, immunoassay kits, and recombinant proteins, announced the launch of Multi-rAb Recombinant Secondary Antibodies, the newest generation of secondary antibodies designed to deliver unparallel specificity and reproducibility in widely used immunoassays. Secondary antibodies are one of the most widely used reagents, making them indispensable tools for biomedical research.
Report Analysis:

Techniques of Production of Recombinant Proteins:
  • Genetic engineering, DNA cloning and vector design (e.g. plasmid vectors).
  • Transferring DNA sequences of interest into host cells (transformation into bacterial, yeast, mammalian or transfection into mammalian cells).
  • Protein expression and purification (e.g. with SDS-page or affinity chromatography).
Segmentation:

By Drug Class:
  • Plasma Protein
  • Growth Factors
  • Fusion Protein
  • Monoclonal Antibodies
  • Hormones
  • Enzyme
  • Coagulation Factors
  • Others
By Host Cell Type:
  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Others
By Application:
  • Oncology
  • Hematology
  • Immunology
  • Endocrinology
  • Infectious Disease
  • Cardiovascular Disease
  • Others
By End User:
  • Biotechnology and Pharmaceutical Companies
  • Research Organizations and Laboratories
  • Diagnostic Centers
  • Others
By Region:
  • North America
o U.S.

Canada
  • Europe
o Germany

U.K.

France

Russia

Italy

Spain

Netherlands

Rest of Europe
  • Asia Pacific
o China

India

Japan

Australia

Indonesia

Malaysia

South Korea

Rest of Asia Pacific
  • Latin America
o Brazil

Mexico

Argentina

Rest of Latin America
  • Middle East & Africa
o GCC

Israel

South Africa

Rest of Middle East & Africa

The report also includes a competitive analysis with a detailed SWOT review, examining the strengths, weaknesses, opportunities, and threats of each leading company, as well as their market share and product offerings.

Recombinant Therapeutics Antibodies and Proteins Market Companies:

Amgen Inc.

Biogen

Sanofi

Abbott

Merck & Co., Inc.

Eli Lilly and Company

Novo Nordisk A/S

F. Hoffmann-La Roche Ltd

Pfizer Inc.

Johnson & Johnson Services, Inc.

Sino Biological, Inc.

The Native Antigen Company

exonbio

Bio-Techne

What Our Report Delivers:
  • Regional & Country-Level Market Insights: Detailed market share analysis across key regions and countries to help you understand competitive positioning.
  • Guidance for New Market Players: Actionable strategic recommendations for businesses entering the market, ensuring a strong foothold from the start.
  • Comprehensive Market Forecasts: Reliable data projections for 2024, 2025, 2026, 2028, and 2032 to support long-term planning and investment decisions.
  • In-Depth Market Dynamics: Analysis of drivers, restraints, opportunities, and emerging threats, along with challenges and high-potential investment areas.
  • Data-Driven Business Strategies: Expert recommendations tailored to key market segments, backed by precise market evaluations.
  • Competitive Intelligence: Mapping of prevailing industry trends and competitor strategies to identify growth opportunities.
  • Detailed Company Profiles: In-depth analysis of major players, including their business strategies, financial performance, and recent developments.
  • Supply Chain Innovations: Insights into the latest technological advancements and trends shaping supply chain efficiency.
FAQs:

Key Questions Answered in the Report.

1. What was the Recombinant Therapeutics Antibodies and Proteins Market size in 2025?

2. What is projected growth rate of the Recombinant Therapeutics Antibodies and Proteins Market during 2025-2035?

3. What are the key factors driving the Recombinant Therapeutics Antibodies and Proteins Market growth?

4. What are leading players in the Recombinant Therapeutics Antibodies and Proteins Market ?

5. What are the key regions analyzed in the Recombinant Therapeutics Antibodies and Proteins Market ?

6. Which region is dominating in the Recombinant Therapeutics Antibodies and Proteins Market ?

Table of Contents

180 Pages
Recombinant Therapeutics Antibodies Table of Contents
Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Preview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Host Cell Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
Opportunity Map Analysis
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Market Trends
Product Launch
Merger and Acquisitions
Impact Analysis
PEST Analysis
Porter’s Analysis
Selection and Screening of Monoclonal Antibodies
Protein Structure and Formulation
Development of assays for humoral and cellular immune response
Market Segmentation, By Drug Class, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Plasma Protein
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Growth Factors
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Fusion Protein
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Monoclonal Antibodies
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Hormones
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Enzyme
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Coagulation Factors
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Host Cell Type, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Mammalian Cells
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Bacterial Cells
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Yeast Cells
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Oncology
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Hematology
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Immunology
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Endocrinology
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Infectious Disease
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Cardiovascular Disease
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By End User, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Biotechnology and Pharmaceutical Companies
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Research Organizations and Laboratories
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Diagnostic Centres
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Regional Trends
North America
Market Size and Forecast (USD Bn), By Drug Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Host Cell Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
U.S
Canada
Asia Pacific
Market Size and Forecast (USD Bn), By Drug Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Host Cell Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
China
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia Pacific
Europe
Market Size and Forecast (USD Bn), By Drug Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Host Cell Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
Germany
U.K.
France
Russia
Italy
Spain
Netherlands
Rest of Europe
Latin America
Market Size and Forecast (USD Bn), By Drug Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Host Cell Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
Brazil
Mexico
Argentina
Rest of Latin America
Middle East and Africa
Market Size and Forecast (USD Bn), By Drug Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Host Cell Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
GCC
Israel
South Africa
Rest of Middle East and Africa

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us